The Central Coast Hunter is home to leading scientists, physicians and healthcare professionals. It boasts world-class medical research and healthcare infrastructure, a stable socio-economic environment, a diverse population and is supported by Australia’s strong intellectual property regime.

DOWNLOAD THIS SECTION

CLINICAL TRIALS IN CENTRAL COAST HUNTER WEB VERSION 2

CLINICAL TRIALS IN CENTRAL COAST HUNTER PRINT VERSION 2

CCH Clinical Trials situation:

  • 431 clinical trials currently underway
  • Existing proven clinical trials infrastructure
  • 80% of clinical trials sponsored by industry
  • 10% paediatric/90% adult population split
  • Ready access to experienced, renowned clinicians
  • Diverse therapeutic-area clinical research experience
  • A diverse, stable population including regional, rural and remote communities
  • Additional clinical trials capacity due to the process improvements currently underway

Source: HUNTER AND CENTRAL COAST CAPABILITY AUDIT OF THE MEDICAL TECHNOLOGY AND PHARMACEUTICAL SECTOR, by Mark Flynn, PhD, MBA of Global Edge MedTech Consulting 2020

WHAT MAKES CCH AN IDEAL DESTINATION FOR CLINICAL TRIALS?

  • Quality medical research infrastructure and a skilled, experienced workforce
  • Clinical leaders in diverse therapeutic areas
  • A world-class healthcare system
  • A diverse, English-speaking population
  • Clinical data which complies with the highest international standards

Additionally, Australia’s efficient regulatory system, including a rapid clinical trial approval system, well-established clinical trial infrastructure, experienced and well qualified personnel and globally competitive tax incentives for research and development (R&D) investment, all help make Australia a leading destination for clinical trials.

Source: https://www.austrade.gov.au/international/invest/opportunities/medical-science-and-technologies

Australia offers:

  • Attractive research & development (R&D) tax incentives for clinical trials
  • A fast, pragmatic regulatory pathway
  • A strong intellectual property system
  • A national focus on continuous improvement through government reform and policy innovation
  • Proximity to Asia
  • Australia’s Medical Research Future Fund that support research projects and infrastructure

Global companies benefit from streamlined processes and clinical trial protocols which are immediately globally transferable, ensuring outcomes that are reliable, highly respected and can be made readily available in other jurisdictions.

The Australian Government, in partnership with industry and other stakeholders, has introduced a number of reforms to make Australia an even more attractive place to conduct clinical trials whilst maintaining the highest quality and ethical standards. They include initiatives to improve the speed of study approvals, boost patient recruitment and standardise and reduce costs associated with clinical trials in Australia.